Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - January 2013


Medical Affairs Seminar - Launching a High-Value Medical & Scientific Affairs Team

22 Jan 2013 - 23 Jan 2013 - Boston, MA, USA



Bookmark and Share


Medical Affairs Seminar - Launching A High-Value Medical & Scientific Affairs Team

During the past decade, Medical Affairs has become a critical function within all pharmaceutical and biotechnology companies. A high-performance Medical Affairs team will not only support but drive the safe, effective and appropriate use of medications throughout a product lifecycle. A Medical Affairs Department is now a necessity rather than a luxury. 

Launching a High Value Medical Affairs Team is an interactive learning opportunity for professionals who are setting up, expanding or restructuring Medical Affairs Departments and Groups. This program will help participants identify the needs of their organization, the appropriate structure and organizational alignment and identify critical functions, and will clarify many other operational aspects that are key to building a sustainable and respected department.

This conference will offer an opportunity to learn from others who have built Medical Affairs teams from the ground up, including the good, the bad and the ugly. Finally, and most important, the seminar is an excellent opportunity to pause from everyday duties, in order to reflect on your medical affairs strategies and tactics, and exchange experiences through networking and discussion with your peers.



Further information
Scientific News
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
Study Finds Factors That May Influence Influenza Vaccine Effectiveness
Researchers at NIH have suggested that the long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited.
BMS’s Opdivo Clinical Trial Shows Promise
Safety profile of the combination regimen from CheckMate -069 was consistent with previously reported studies and adverse events were managed using established safety algorithms.
Treatment of Common Prostate Cancer
Researchers at UTSW have found that the prostate cancer treatments suppress immune response and may promote relapse.
Cancer Drug Could Treat Blood Vessel Deformities
A drug currently being trialled in cancer patients could also be used to treat an often incurable condition that can cause painful blood vessel overgrowths inside the skin.
Structure of Crucial Enzyme Identified
Researchers at UTSW have determined the atomic structure of an enzyme that plays an essential role in cell division and better treatment of cancer.
New Immunotherapy Trial for Type 1 Diabetes
The search for a treatment for Type 1 diabetes (T1D) - which affects over 400,000 people in the UK – will be stepped up with the start of a new phase one clinical trial at Guy’s Hospital in London.
Recruitment of First Patient in Clinical Study
Company has announced recruitment of first patient in clinical study assessing Visco-ease with Beatson Cancer Centre for the treatment of RIX.
Fighting Prostate Cancer
Identifying the most promising compounds which can be used as medications for prostate cancer.
Chi-Med Initiates Sulfatinib Phase III Registration Study
Company has initiated SANET-p, a Phase III registration trial of sulfatinib with pancreatic neuroendocrine tumors (“NETs”).
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!